| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/27/2013 | EP2571492A2 Improved liposomal formulations of lipophilic compounds |
| 03/27/2013 | EP2571489A1 Injectable emulsion of sedative hypnotic agent |
| 03/27/2013 | EP2571488A1 Pharmaceutical composition of ibuprofen for injection |
| 03/27/2013 | EP2571486A1 Dry powder inhalation composition |
| 03/27/2013 | EP2571484A2 Effervescent formulations |
| 03/27/2013 | EP2571361A1 Pyrazolopyrimidine compounds for the treatment of cancer |
| 03/27/2013 | EP2571360A1 Methods and formulations for oxytocin treatment of substance use, psychiatric and other disorders |
| 03/27/2013 | EP2571359A1 Novel prolylcarboxypeptidase inhibitors |
| 03/27/2013 | EP2571358A1 Combination |
| 03/27/2013 | EP2571357A1 Chemical compounds, compositions and methods for kinase modulation |
| 03/27/2013 | EP2571356A1 Spiro isoxazoline compounds as sstr5 antagonists |
| 03/27/2013 | EP2571355A1 Crystalline hydrochloride salt of darunavir |
| 03/27/2013 | EP2571354A1 Methods for inhibiting muscle atrophy |
| 03/27/2013 | EP2571353A1 Modulators of 5-ht receptors and methods of use thereof |
| 03/27/2013 | EP2571352A1 Selective hdac inhibitors |
| 03/27/2013 | EP2571351A1 Diazeniumdiolate cyclohexyl derivatives |
| 03/27/2013 | EP2214480B1 Methods of treating non-alcoholic steatohepatitis (nash) using cysteamine products |
| 03/27/2013 | CN1972916B 肉桂酰胺类化合物 Cinnamic amides |
| 03/27/2013 | CN1964956B Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 03/27/2013 | CN1909780B Medium chain peroxycarboxylic acid compositions |
| 03/27/2013 | CN1852721B Compositions and methods for treating, preventing and/or ameliorating cancers, the onset of cancers or the symptoms of cancers |
| 03/27/2013 | CN1774236B Keratolytic composition with anti-allergic anti-inflammatory properties |
| 03/27/2013 | CN1681791B 8-羟基喹啉衍生物 8-hydroxyquinoline derivative |
| 03/27/2013 | CN1671391B Novel methods and compositions for alleviating pain |
| 03/27/2013 | CN103003441A Procedure for biphasic preparation of liposomes and application thereof in manufacturing diagnostic reagents |
| 03/27/2013 | CN103003430A Antisense molecules and methods for treating pathologies |
| 03/27/2013 | CN103003427A Novel nucleic acid having adjuvant activity and use thereof |
| 03/27/2013 | CN103003303A Improved anti-serum albumin binding variants |
| 03/27/2013 | CN103003293A Aminoglycoside Derivatives |
| 03/27/2013 | CN103003292A 化妆品组合物 Cosmetic composition |
| 03/27/2013 | CN103003283A Crystalline forms of kinase inhibitors |
| 03/27/2013 | CN103003282A A process for the preparation of novel porphyrin derivatives and their use as PDT agents and fluorescence probes |
| 03/27/2013 | CN103003281A Pyrrolo [2, 3 - b] pyrazine - 7 - carboxamide derivatives and their use as jak and syk inhibitors |
| 03/27/2013 | CN103003280A Deuterated pyrrolopyrimidine compounds as inhibitors of CDK4/6 |
| 03/27/2013 | CN103003279A Purine compounds selective for Pi3K P110 delta, and methods of use |
| 03/27/2013 | CN103003275A Benzoquinolone inhibitors of vmat2 |
| 03/27/2013 | CN103003274A Pyrrolopyridine inhibitors of kinases |
| 03/27/2013 | CN103003273A Pyrazolopyridine kinase inhibitors |
| 03/27/2013 | CN103003271A Novel rhodanine derivatives, method for preparing same, and pharmaceutical composition for the prevention or treatment of AIDS containing the rhodanine derivatives as active ingredients |
| 03/27/2013 | CN103003270A Benzofuranone compound and pharmaceutical composition containing same |
| 03/27/2013 | CN103003269A Substituted heterocyclyl benzyl pyrazoles, and use thereof |
| 03/27/2013 | CN103003267A Sigma receptor inhibitors |
| 03/27/2013 | CN103003266A Hydroxyalkyl benzyl pyrazoles, and use thereof for the treatment of hyperproliferative and angiogenic diseases |
| 03/27/2013 | CN103003264A Novel pyrimidine derivatives |
| 03/27/2013 | CN103003262A Nitrogenated aromatic heterocyclic ring derivative |
| 03/27/2013 | CN103003255A Process and assembly for producing alkylene oxides and glycol ethers |
| 03/27/2013 | CN103003253A Acid addition salts of the 2-[2-[[(4-methoxy-2,6-dimethylphenyl) sulfonyl]-(methyl)amino]ethoxy]-n-methyl-n-[3- (4-methylpiperazin-1-yl)cyclohexyl] acetamide and the use thereof as bradykinin b1 receptor antagonists |
| 03/27/2013 | CN103003250A Bicyclic azaheterocyclic carboxamides as inhibitors of the kinase p70s6k |
| 03/27/2013 | CN103003242A PYRidin-2-yl sulfanyl acid esters and process for the preparation thereof |
| 03/27/2013 | CN103003236A Novel thiourea or urea derivative, preparation method thereof, and pharmaceutical composition for preventing or treating AIDS, containing same as active ingredient |
| 03/27/2013 | CN103003234A N-hydroxyformamide derivative and pharmaceutical containing same |
| 03/27/2013 | CN103003233A Novel hydroxamic acid derivative |
| 03/27/2013 | CN103003228A Compounds based on ibuprofen, preparation methods, uses and pharmaceutical preparation thereof |
| 03/27/2013 | CN103002914A Compositions and methods for inhibiting MMSET |
| 03/27/2013 | CN103002900A Transcription factor decoys |
| 03/27/2013 | CN103002899A Piperazinotriazines as PI3K inhibitors for use in the treatment antiproliferative disorders |
| 03/27/2013 | CN103002898A 6-(1-methyl-1h-pyrazol-4-yl)-3-(2-methyl-2h-indazol-5-ylthio)-[1,2,4] triazolo [4,3-b] pyridazine as a c-met inhibitor |
| 03/27/2013 | CN103002897A Certain amino-pyridazines, compositions thereof, and methods of their use |
| 03/27/2013 | CN103002896A Use of levocetirizine and montelukast in the treatment of influenza, common cold and inflammation |
| 03/27/2013 | CN103002895A Method for treating hematological cancers |
| 03/27/2013 | CN103002894A BRAF mutations conferring resistance to BRAF inhibitors |
| 03/27/2013 | CN103002893A Therapeutic agent or prophylactic agent for neuropathic pain |
| 03/27/2013 | CN103002892A Anti-angiogenic composition containing macrolactin A and a derivative thereof as active ingredients |
| 03/27/2013 | CN103002891A Ratiometric combinatorial drug delivery |
| 03/27/2013 | CN103002890A Novel compounds and compositions for targeting cancer stem cells |
| 03/27/2013 | CN103002889A Sn-2-monoacylglycerols and lipid malabsorption |
| 03/27/2013 | CN103002888A Anticoagulant compounds and their use |
| 03/27/2013 | CN103002887A Methods and compositions related to a retinoid receptor-selective pathway |
| 03/27/2013 | CN103002886A Treatment of osteoporosis |
| 03/27/2013 | CN103002884A Intraocular pressure reduction with intracameral bimatoprost implants |
| 03/27/2013 | CN103002883A Pharmaceutical formulation in the form of bilayered tablets comprising HMG-CoA reductase inhibitor and irbesartan |
| 03/27/2013 | CN103002880A Solid dispersions containing kinase inhibitors |
| 03/27/2013 | CN103002877A A sustained release formulation of methotrexate as a disease-modifying antirheumatic drug (DMARD) and an anti-cancer agent |
| 03/27/2013 | CN103002876A Improved liposomal formulations of lipophilic compounds |
| 03/27/2013 | CN103002875A Topical formulation for a jak inhibitor |
| 03/27/2013 | CN103002873A Parenteral pharmaceutical form which releases aromatse inhibitor and gestagens, for the treatment of endometriosis |
| 03/27/2013 | CN103002871A Malvidin for promoting hair growth |
| 03/27/2013 | CN103002738A Chemical compounds, compositions and methods for kinase modulation |
| 03/27/2013 | CN103002735A Modulators of 5-ht receptors and methods of use thereof |
| 03/27/2013 | CN102993348A Sevelamer niacin, preparation method and application |
| 03/27/2013 | CN102993320A Isolates of radix hedysari polysaccharide 3 and application thereof |
| 03/27/2013 | CN102993250A C-3 substituted-9-deoxidized-9A-aza-9A-high erythromycin A derivative |
| 03/27/2013 | CN102993239A Platinum compound of succinic acid derivative with leaving group containing amino or alkylamino |
| 03/27/2013 | CN102993212A Picrinine salt and pharmaceutical application thereof |
| 03/27/2013 | CN102993210A New thienopyridine compound |
| 03/27/2013 | CN102993208A Noradrenaline and selective serotonin receptor blocking agent and application thereof |
| 03/27/2013 | CN102993204A Certain chemical entities, compositions and methods |
| 03/27/2013 | CN102993203A Preparation of 8-benzyl xanthine derivative and application |
| 03/27/2013 | CN102993202A Salts and crystall forms of 2-methyl-2-[4-(3-methyl-2-oxo-8-quinolin-3-yl-2,3-dihydro-imidazo[4,5-c]quinolin-1-yl)-phenyl]-propionitrile |
| 03/27/2013 | CN102993201A 6-(4-hydroxyl-phenyl)-3-styryl-1H-pyrazole[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitor |
| 03/27/2013 | CN102993200A Paliperidone amino-acid ester and preparation method thereof |
| 03/27/2013 | CN102993199A Heterocycle substituted pyrido-pyrrole kinase inhibitor |
| 03/27/2013 | CN102993197A Tropinone derivative, and preparation method and application thereof |
| 03/27/2013 | CN102993195A Substitutional-2-(chroman-6-oxyl) thiazole and application thereof as medicine |
| 03/27/2013 | CN102993193A Use of nitrogen-3-isoxazolyl-3-4-thienyl-pyrimidyl sulfonyl propanamide derivative in preparing anti-tumor medicines |
| 03/27/2013 | CN102993192A Oxazolidinone compound as well as preparation method and application thereof |
| 03/27/2013 | CN102993186A Novel piperazine derivative |
| 03/27/2013 | CN102993175A Dabigatran derivatives, and preparation method and application thereof |
| 03/27/2013 | CN102993174A Dabigatran etexilate derivative as a prodrug |
| 03/27/2013 | CN102993172A Tricyclic compound with antihistamine activity, preparation method and application |